PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol 353 10 References 1. Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1659-724. 2. Nayak P, Pechacek TF, Slovic P, Eriksen MP. Regretting Ever Starting to Smoke: Results from a 2014 National Survey. Int J Environ Res Public Health. 2017;14(4):12. 3. Leefstijl en (preventief) gezondheidsonderzoek; persoonskenmerken [Internet]. CBS. 2019. Available from: https://opendata.cbs.nl/statline/#/CBS/nl/dataset/83021NED/ table?fromstatweb. 4. Stead LF, Perera R, Bullen C, Mant D, Hartmann‐Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012(11). 5. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017(3). 6. Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017(3). 7. Notley C, Gentry S, Livingstone‐Banks J, Bauld L, Perera R, Hartmann‐Boyce J. Incentives for smoking cessation. Cochrane Database Syst Rev. 2019(7). 8. Odum AL. Delay discounting: I’m a k, you’re a k. J Exp Anal Behav. 2011;96(3):427-39. 9. O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103-24. 10. Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015;372(22):2108-17. 11. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699-709. 12. Halpern SD, Harhay MO, Saulsgiver K, Brophy C, Troxel AB, Volpp KG. A Pragmatic Trial of E-Cigarettes, Incentives, and Drugs for Smoking Cessation. N Engl J Med. 2018;378(24):2302-10. 13. van den Brand FA, Nagelhout GE, Winkens B, Chavannes NH, van Schayck OCP. Effect of a workplace-based group training programme combined with financial incentives on smoking cessation: a cluster-randomised controlled trial. Lancet Public Health. 2018;3(11):e536-e44. 14. Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, et al. Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation. Am J Respir Crit Care Med. 2016;194(8):981-8. 15. Chan A-W, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381(9861):91-2. 16. Milieu RvVe. Loket gezond leven RIVM 2019 [Available from: https://interventies. loketgezondleven.nl/leefstijlinterventies/interventies-zoeken/1400743. 17. Gneezy U, Meier S, Rey-Biel P. When and why incentives (don’t) work to modify behavior. J Econ Perspect. 2011;25(4):191-210. 18. van den Brand FA, Nagelhout GE, Winkens B, Chavannes NH, van Schayck OCP. Effect of a workplace-based group training programme combined with financial incentives on smoking cessation: a cluster-randomised controlled trial. The Lancet Public Health. 2018;3(11):e536-e44. 19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-27.
RkJQdWJsaXNoZXIy MTk4NDMw